Background Image
Table of Contents Table of Contents
Previous Page  108 / 198 Next Page
Information
Show Menu
Previous Page 108 / 198 Next Page
Page Background

C1-02

GENDER DIFFERENCES IN EXPOSURE TO AND OUT-

COMES OF MILD TRAUMATIC BRAIN INJURY IN AMA-

TEUR ADULT SOCCER PLAYERS

Eva Catenaccio

1

, Weiya Mu

1

, Namhee Kim

1

, Molly Zimmerman

1

,

Mark Wagshul

1

, Roman Fleysher

1

, Tamar Glattsein

1

, Malka Zughaft

1

,

Walter Stewart

4

, Richard Lipton

3

, Michael Lipton

1,2

1

Albert Einstein College of Medicine, GMRRC, Bronx, USA

2

Montefiore Medical Center, Radiology, Bronx, USA

3

Montefiore Medical Center, Neurology, Bronx, USA

4

Sutter Healthcare, R&D, Sacromento, USA

Female athletes are at increased risk for sports-related mild traumatic

brain injury (mTBI) and at increased risk for poor mTBI outcomes,

relative to males. Heading in soccer represents a source of repetitive

subconcussive head impacts. Previous research has shown that

heading exposure above a threshold of approximately 1800 headers/

year is associated with deficits in cognitive function including de-

creased verbal memory performance. This study assesses the role of

gender as a predictor of mTBI-associated functional outcomes, in-

cluding cognitive function and post concussive symptoms (PCS), in a

cohort of amateur soccer players. 82 players (41 females and 41 age-

and educated-matched males, ages 18–52) were drawn from an on-

going longitudinal study of sub-concussive and concussive mTBI in

amateur soccer players. All subjects underwent a battery of cognitive

tests and symptoms assessments. Group differences were calculated

between men and women using the Mann-Whitney U-test for heading

exposure, history of concussion, cognitive performance and PCS at

their enrollment visit. Results were corrected for multiple compari-

sons using false discovery rate (FDR) correction (alpha

=

0.05). Men

reported more soccer play and more heading during the 12 months

prior to enrollment (p

=

0.003). Women, however, reported more prior

concussions (p

=

0.001), Women also endorsed significantly more

acute PCS (headaches, dizziness, and nausea/vomiting) than men

(p

=

0.018). However, men demonstrate decreased performance on a

verbal memory task (p

=

0.001). All reported results survived FDR-

correction. These data suggest that women are at increased risk for

concussion and PCS, despite lesser overall frequency of soccer play

and heading. Men, who report greater exposure to heading, show

poorer verbal memory, which is consistent with prior results associ-

ating greater heading exposure with deficits in verbal memory.

Keywords: Gender, Sports Related TBI, Concussion, Post Con-

cussive Symptoms

C1-03

MILITARY DEPLOYMENT INCREASES THE RISK FOR TBI

FOLLOWING DEPLOYMENT

Donald Marion

, Lemma Regasa, Mike Thomas, Ranjodh Gill, Brian

Ivins

Defense and Veterans Brain Injury Center, Clinical Affairs, Silver

Spring, USA

The objective of this study was to compare rates of traumatic brain

injury (TBI) diagnosis before and after overseas military deployment.

We conducted a retrospective examination of a cohort of 119,353

active duty United States military service members (Army, Navy, Air

Force, and Marines) whose

first lifetime

overseas deployment began at

any time between January 1, 2011 and December 31, 2011 and lasted

for at least 30 days. For this cohort, TBI diagnoses were examined

during the 76 weeks prior to deployment, during deployment, and for

76 weeks following the end of deployment. The main outcome

measure was the rate of TBI diagnosis at sequential 4 week intervals.

We found that the risk of being diagnosed with TBI within 4 weeks

after returning from deployment was 8.4 times higher than the average

risk before deployment. The risk gradually decreased thereafter up to

40 weeks post deployment. During the 41 to 76 weeks following

deployment the risk stabilized. The

pre-deployment incidence

of TBI

diagnosis was 119.8/100,00 for all services, and was highest for Army

(147/100,000).

Following deployment

the incidence of TBI diagnosis

was initially as high as 400/100,000 and declined to approximately

200/100,000 at 40 weeks after deployment. At that point the risk ratio

for TBI diagnosis stabilized to 1.7 (95% CI: 1.6–1.8) during the 41 to

76 weeks after injury, compared to the pre-deployment risk. These

data suggest an increased rate of TBI diagnosis following deployment

which, during the first 40 weeks, is most likely a result of a delay in

the diagnosis of TBIs that actually occurred while service members

were deployed. Both the Department of Defense and the Department

of Veterans Affairs have mechanisms for aggressive post-deployment

identification of concussions that occured during deployment. How-

ever, the stable but increased rate of TBI diagnoses observed at 40–76

weeks following deployment suggests that the

experience of deploy-

ment

may increase risk taking behaviors of service members, leading

to an increased incidence of TBIs.

Keywords: concussion, Military, deployment, concussion risk,

garrison concussion

C1-04

VERY EARLY ADMINISTRATION OF PROGESTERONE

DOES NOT IMPROVE COGNITIVE OUTCOMES IN PA-

TIENTS WITH MODERATE TO SEVERE TBI

Felicia Goldstein

1

, Angela Caveney

3

, Vicki Hertzberg

2

, Robert

Silbergleit

3

, Sharon Yeatts

5

, Yuko Palesch

5

, Harvey Levin

4

,

David

Wright

1

1

Emory, Emergency/Neurology, Atlanta, US

2

Michigan, Emergency, Ann Arbor, US

3

Baylor, PM&R, Houston, US

4

South Carolina, Statistics, Charleston, US

5

Rollins, Biostatistics, Atlanta, US

Objectives:

Despite promising Phase II clinical trial data, early ad-

ministration of progesterone did not improve gross functional out-

comes or mortality in two recent large confirmatory phase III trials of

patients with moderate to severe TBI. However, these outcomes may

be insufficiently sensitive to treatment effects. This analysis of sec-

ondary neuropsychological outcomes evaluates whether progesterone

is associated with improved recovery of cognitive functioning.

Methods:

A Phase III, double-blind, placebo-controlled trial

(ProTECT III) was conducted at 49 Level I trauma centers in the

United States. Adults with moderate to severe TBI (GCS score 4 to

12) were randomized to intravenous progesterone or placebo initiated

within 4 hours of injury and administered for 96 hours. At 6 months

(

30 days), participants capable of testing underwent evaluation of

memory, executive functioning, attention, and language.

Results:

546 subjects were testable (263 progesterone, 283 placebo).

Analyses of covariance, controlling for potential confounders, did not

reveal significant treatment effects for Buschke immediate (41.8 SD-

11 progesterone, 42.3 SD-12 placebo) or delayed (5.7 SD-3 proges-

terone, 5.7 SD-3 placebo) word recall, Trails A sequencing speed

(36.5 SD-18 progesterone, 37.0 SD-19 placebo) and Trails B set

shifting speed (94.3 SD-54 progesterone, 95.2 SD-57 placebo), digit

span forward (9.2 SD-2.1 progesterone, 9.4 SD2.4 placebo) and

A-72